Jindu Biotech completes nearly 100 million RMB Series A financing round led by Gaotejia.

Funding Rounds

▤ Summary

Jindu Biotech completed a nearly 100 million RMB Series A round led by Gaotejia. The company plans to use the capital to deepen its physical AI infrastructure, upgrade the BioFord Agent platform, and expand globally. Its software platform combines biology and AI for life sciences use cases. This is a funding event with clear growth and product development implications for a software-enabled life sciences vendor.

$ Funding

$
Amount $13.9M Total raised
□
Date June 12, 2026 Announcement date
◎
Investors - Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies